Overview
Nystagmus refers to involuntary eye movements that can significantly affect visual function and quality of life. Acquired nystagmus, often secondary to neurological conditions like multiple sclerosis or stroke, requires specific management strategies.Diagnosis
Clinical Presentation: Characteristic involuntary eye movements 2.
Diagnostic Tests: Ophthalmic examination, including visual acuity testing and nystagmus characterization 2.
Imaging: MRI or CT scans to identify underlying causes such as stroke or multiple sclerosis 2.Management
First-Line Treatments:
- Gabapentin: Commonly used for symptom management 2.
- Baclofen: Another frequently prescribed medication for symptom relief 2.
Adjunctive Treatments:
- Clonazepam, Carbamazepine, Benzhexol, Ondansetron, Buspirone, Memantine, Botulinum Toxin: Used less frequently, with variable reported efficacy 2.Special Populations
Neurological Comorbidities: Management often focuses on treating underlying conditions like multiple sclerosis or stroke 2.
No Specific Data on Pregnancy, Pediatrics, or Elderly: Abstracts do not provide detailed guidance for these populations 12.Key Recommendations
Utilize Gabapentin and Baclofen as First-Line Medications for Symptom Management (Evidence: Moderate 2).
Consider Imaging (MRI/CT) to Identify Underlying Causes of Acquired Nystagmus (Evidence: Moderate 2).
Monitor for Side Effects, Particularly with Baclofen and Gabapentin Treatments (Evidence: Expert opinion 2).References
1 Frazão YS, Manzi SB, Krakauer L, Berretin-Felix G. Utilization of electromyographic biofeedback in speech therapy to attenuate the signs of facial aging: a case report. CoDAS 2023. link
2 Choudhuri I, Sarvananthan N, Gottlob I. Survey of management of acquired nystagmus in the United Kingdom. Eye (London, England) 2007. link
3 Patterson PD, Moore CG, Brice JH, Baxley EG. Use of ED diagnosis to determine medical necessity of EMS transports. Prehospital emergency care 2006. link